Conditions | Yield |
---|---|
With dinitrogen tetroxide impregnated on activated charcoal In dichloromethane at 20℃; for 4h; | 90% |
With cross-linked polyvinylpyrrolidone*N2O4; dinitrogen tetraoxide In dichloromethane at 20℃; for 3.33333h; | 89% |
With hydrogenchloride; sodium nitrite In 2-methyltetrahydrofuran; diethyl ether; water at 25℃; under 6000.6 Torr; for 1.3h; Flow reactor; | 83% |
Conditions | Yield |
---|---|
Stage #1: urea; methylamine With hydrogenchloride In water for 3h; Reflux; Stage #2: With sodium nitrite at 0 - 20℃; | 70% |
With hydrogenchloride In water at -15 - 110℃; |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
With sulfuric acid; water at 0℃; | 51% |
Conditions | Yield |
---|---|
With hydrogenchloride; sodium nitrite | |
Stage #1: N-acetyl-N'-methylurea With hydrogenchloride at 100℃; for 0.0666667h; Stage #2: With sodium nitrite cooling; Further stages.; | 8 g |
Stage #1: N-acetyl-N'-methylurea With hydrogenchloride In water at 100℃; for 0.2h; Stage #2: With sodium nitrite In water Cooling with ice; | 9 g |
Conditions | Yield |
---|---|
With water bei Siedetemperatur und anschliessende Umsetzung mit NaNO2 und verd. H2SO4 unter Kuehlung; | |
Stage #1: methylamine hydrochloride; urea In water at 105℃; for 3.5h; Stage #2: With sodium nitrite In water at 40℃; for 0.25h; Stage #3: With sulfuric acid In tetrahydrofuran; water at 0 - 5℃; for 2h; | |
Stage #1: methylamine hydrochloride; urea In water at 105℃; for 3.5h; Stage #2: With sodium nitrite In water at 40℃; for 0.25h; |
Methylnitrosocyanamid
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
With sulfuric acid In dichloromethane |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
With water; sodium nitrite |
Conditions | Yield |
---|---|
Stage #1: acetamide With bromine; sodium hydroxide In water at 100℃; Stage #2: With hydrogenchloride at 100℃; for 0.002h; Stage #3: With sodium nitrite In water Cooling with ice; | 9 g |
1-methyl-1-nitrosourea
dikegulac
methyl 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonate
Conditions | Yield |
---|---|
With potassium hydroxide 1.) ether, ice-bath cooling, 2 min, 2.) methanol, gently warming; | 100% |
Conditions | Yield |
---|---|
With potassium hydroxide In diethyl ether; water at 0℃; for 0.25h; | 100% |
1-methyl-1-nitrosourea
1-adamantylacetyl chloride
1-diazo-3-(1-adamantyl)-2-propanone
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; for 0.25h; Inert atmosphere; Stage #2: 1-adamantylacetyl chloride In diethyl ether at 0 - 20℃; Inert atmosphere; | 100% |
1-methyl-1-nitrosourea
ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate
4-ethoxycarbonyl-3,3-bis(trifluoromethyl)-2-pyrazoline
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; Stage #2: ethyl 4,4,4-trifluoro-3-(trifluoromethyl)crotonate In diethyl ether at 20℃; for 1h; | 99% |
1-methyl-1-nitrosourea
Nα-phthaloyl-L-phenylalanine
(S)-methyl 2-(1,3-dioxoisoindolin-2-yl)-3-phenylpropanoate
Conditions | Yield |
---|---|
With potassium hydroxide In diethyl ether; water | 99% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
With potassium hydroxide In diethyl ether; water for 0.5h; | 99% |
(E)-4,4,5,5-tetramethyl-2-(3-methylbut-1-en-1-yl)-1,3,2-dioxaborolane
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether; water for 0.0833333h; Cooling with ice; Stage #2: (E)-4,4,5,5-tetramethyl-2-(3-methylbut-1-en-1-yl)-1,3,2-dioxaborolane With palladium diacetate In diethyl ether; water Cooling with ice; | 99% |
With palladium diacetate; potassium hydroxide In diethyl ether; water at 20℃; | 99% |
1-methyl-1-nitrosourea
spiro<2.4>hepta-4,6-diene 2,6>deca-3,8-diene)-10-spirocyclopropane>
dispiro2,6.08,10>undec-4-ene-12',1''-cyclopropane>
Conditions | Yield |
---|---|
With potassium hydroxide; bis(benzonitrile)palladium(II) dichloride In dichloromethane at 10℃; for 0.333333h; | 98% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
With potassium hydroxide In diethyl ether; dichloromethane; water for 2h; | 98% |
norborn-2-ene
1-methyl-1-nitrosourea
exo-3,4-diazatricyclo[5.2.1.02,6]dec-3-ene
Conditions | Yield |
---|---|
With potassium hydroxide In diethyl ether; water at -5℃; for 1h; | 98% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether; water at 0℃; Stage #2: 2-But-2-ynyl-2-[(E)-3-((1S,2R)-2-carboxy-cyclopropyl)-allyl]-malonic acid dimethyl ester In diethyl ether Further stages.; | 98% |
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide Stage #2: C28H28O12S2 | 98% |
1-methyl-1-nitrosourea
5,6-O-isopropylidene-L-ascorbic acid
5,6-O-isopropylidene-3-O-methyl-L-ascorbic acid
Conditions | Yield |
---|---|
With potassium hydroxide In methanol at -20℃; | 97% |
1-methyl-1-nitrosourea
1-(1-fluorovinyl)-1-methylcyclopropane
Conditions | Yield |
---|---|
With potassium hydroxide; palladium(II) acetylacetonate In dichloromethane; pentane | 97% |
1-methyl-1-nitrosourea
2-[1-((4S,5S)-5-Benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-succinic acid 1-ethyl ester
2-[1-((4S,5S)-5-Benzyloxymethyl-2,2-dimethyl-[1,3]dioxolan-4-yl)-meth-(E)-ylidene]-succinic acid 1-ethyl ester 4-methyl ester
Conditions | Yield |
---|---|
With triethylamine In various solvent(s) for 48h; Ambient temperature; | 96% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; for 0.166667h; Stage #2: (4R,7S,9S,E)-9-(benzyloxy)-7-hydroxy-4-(methoxymethoxy)dec-2-enoic acid In diethyl ether for 0.166667h; | 96% |
1-methyl-1-nitrosourea
dimethyl acetylenedicarboxylate
triphenylphosphine
Conditions | Yield |
---|---|
In hexane; ethyl acetate at 20℃; for 1.5h; | 95% |
1-methyl-1-nitrosourea
N-(tert-butyloxycarbonyl)-S-(4-methoxybenzyl)cysteine
chloroformic acid ethyl ester
[(R)-3-diazo-1-(4-methoxy-benzylsulfanylmethyl)-2-oxo-propyl]-carbamic acid tert-butyl ester
Conditions | Yield |
---|---|
Stage #1: N-(tert-butyloxycarbonyl)-S-(4-methoxybenzyl)cysteine; chloroformic acid ethyl ester With 4-methyl-morpholine In tetrahydrofuran at -25℃; for 1h; Stage #2: 1-methyl-1-nitrosourea With potassium hydroxide In tetrahydrofuran; diethyl ether; water at -25 - 20℃; for 3h; | 95% |
Conditions | Yield |
---|---|
With potassium hydroxide at 0℃; Inert atmosphere; | 95% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With sodium hydroxide In diethyl ether; water at 0℃; for 0.25h; Stage #2: 5-bromo-1-nitro-2-propoxy-3-vinylbenzene With palladium diacetate In diethyl ether; dichloromethane at 0℃; for 1h; | 95% |
1-methyl-1-nitrosourea
amphidinin B
dimethyl ester of amphidinin B
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With sodium hydroxide In water Stage #2: amphidinin B In diethyl ether at 0℃; Inert atmosphere; | 94% |
1-methyl-1-nitrosourea
tert-butyl 2-oxo-7-azaspiro[3.5]nonane-7-carboxylate
tert-butyl 2-oxo-8-azaspiro[4.5]decane-8-carboxylate
Conditions | Yield |
---|---|
With potassium hydroxide In 2-methyltetrahydrofuran; methanol | 93% |
1-methyl-1-nitrosourea
4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoic acid
methyl 4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoate
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether at 0℃; for 0.166667h; Stage #2: 4-(5-iodo-2-formyl-3-methyl-1H-4-pyrrolyl)butanoic acid In methanol; diethyl ether for 0.166667h; | 90% |
1-methyl-1-nitrosourea
(R)-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoic acid
(R)-methyl-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoate
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether Stage #2: (R)-2-(4-cyano-3-(trifluoromethyl)phenylamino)-3-hydroxypropanoic acid In tetrahydrofuran; diethyl ether at 0℃; for 1h; | 90% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
Stage #1: 1-methyl-1-nitrosourea With potassium hydroxide In diethyl ether; water at 0℃; Stage #2: 2,3-diethyl-7-isobutyl-8-methyl-(10H)-dipyrrin-1-one-9-carboxylic acid In methanol; diethyl ether; water at 20℃; for 0.583333h; | 90% |
1-methyl-1-nitrosourea
4-chloro-N-({4-chloro-3-[(3-cyano-5-ethenylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide
4-chloro-N-({4-chloro-3-[(3-cyano-5-cyclopropylphenyl)oxy]-2-fluorophenyl}methyl)-1-({[2-(trimethylsilyl)ethyl]oxy}methyl)-1H-imidazole-5-carboxamide
Conditions | Yield |
---|---|
With potassium hydroxide; palladium diacetate In diethyl ether; dichloromethane; water at 0℃; for 1h; | 90% |
Conditions | Yield |
---|---|
With palladium(II) acetylacetonate In potassium hydroxide; dichloromethane at 5 - 8℃; | 89% |
Conditions | Yield |
---|---|
With palladium(II) acetylacetonate In potassium hydroxide; dichloromethane; pentane at 5 - 8℃; | 89% |
1-methyl-1-nitrosourea
Conditions | Yield |
---|---|
With potassium hydroxide In tetrahydrofuran; diethyl ether; water | 89% |
NTP 10th Report on Carcinogens. IARC Cancer Review: Group 2A IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 ,1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Human Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 17 ,1978,p. 227.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Sufficient Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 17 ,1978,p. 227.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) , IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 1 ,1972,p. 125.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program. Community Right-To-Know List. Reported in EPA TSCA Inventory.
N-Methyl-N-nitrosourea(CAS NO.684-93-5) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids. It is used as precursor of diazomethane. It has a cytotoxicity effect. This product contains an undetermined amount of water. N-Methyl-N-nitrosourea is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, increased fetal resorption, and fetal growth retardation.
Physical properties about N-Nitroso-N-methylurea are: (1)ACD/LogP: -0.302; (2)ACD/LogD (pH 5.5): -0.30; (3)ACD/LogD (pH 7.4): -0.30; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 16.32; (7)ACD/KOC (pH 7.4): 16.32; (8)#H bond acceptors: 5; (9)#H bond donors: 2; (10)#Freely Rotating Bonds: 1; (11)Index of Refraction: 1.545; (12)Molar Refractivity: 22.2 cm3; (13)Molar Volume: 70.241 cm3; (14)Polarizability: 8.801 10-24cm3; (15)Surface Tension: 61.148998260498 dyne/cm; (16)Density: 1.468 g/cm3; (17)Flash Point: 53.143 °C; (18)Enthalpy of Vaporization: 40.078 kJ/mol; (19)Boiling Point: 164.26 °C at 760 mmHg; (20)Vapour Pressure: 1.98300004005432 mmHg at 25°C
When you are using this chemical, please be cautious about it as the following:
1. Avoid exposure - obtain special instruction before use;
2. In case of accident or if you feel unwell, seek medical advice immediately (show label where possible);
3. Avoid contact with skin and eyes;
4. Do not breathe dust;
You can still convert the following datas into molecular structure:
(1)InChI=1S/C2H5N3O2/c1-5(4-7)2(3)6/h1H3,(H2,3,6);
(2)InChIKey=ZRKWMRDKSOPRRS-UHFFFAOYSA-N;
(3)SmilesN(C(N)=O)(N=O)C
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
hamster | LD50 | subcutaneous | 113mg/kg (113mg/kg) | British Journal of Cancer. Vol. 29, Pg. 359, 1974. | |
hamster | LDLo | intravenous | 42mg/kg (42mg/kg) | Journal of Pathology and Bacteriology. Vol. 92, Pg. 35, 1966. | |
mammal (species unspecified) | LD50 | intravenous | 110mg/kg (110mg/kg) | Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975. | |
mammal (species unspecified) | LD50 | oral | 110mg/kg (110mg/kg) | Gann Monograph on Cancer Research. Vol. 17, Pg. 107, 1975. | |
mouse | LD50 | intraperitoneal | 144mg/kg (144mg/kg) | Cancer Research. Vol. 30, Pg. 11, 1970. | |
rat | LD50 | intraperitoneal | 110mg/kg (110mg/kg) | Nature. Vol. 222, Pg. 1064, 1969. | |
rat | LD50 | intravenous | 108mg/kg (108mg/kg) | Naunyn-Schmiedebergs Archiv fuer Pharmakologie und Experimentelle Pathologie. Vol. 257, Pg. 296, 1967. | |
rat | LD50 | oral | 110mg/kg (110mg/kg) | Zeitschrift fuer Krebsforschung. Vol. 69, Pg. 103, 1967. | |
rat | LDLo | implant | 30mg/kg (30mg/kg) | KIDNEY, URETER, AND BLADDER: OTHER CHANGES | Chemico-Biological Interactions. Vol. 5, Pg. 139, 1972. |
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View